Gossamer sells rights to drug it hopes can rival a new Merck therapy
Gossamer Bio has sold rights to an experimental drug that could rival a new medicine from Merck & Co., in a deal at least one analyst believes “bodes well” for the company. On Monday, Gossamer and the Italy-based Chiesi Farmaceutici announced a …